Clinical Trial Update: Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating a serotonin and norepinephrine reuptake inhibitor for improving outcomes in Meniere's disease has completed and posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease

Drugs mentioned

• Serotonin and norepinephrine reuptake inhibitor (SNRI)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Meniere Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-06-24